vimarsana.com

Latest Breaking News On - க்ளென் ரேண்டால் - Page 1 : vimarsana.com

Existing drug may be effective in treating SARS-CoV-2

Existing drug may be effective in treating SARS-CoV-2 Scientists from the University of Chicago have found that the drug masitinib may be effective in treating COVID-19. The drug, which has undergone several clinical trials for human conditions but has not yet received approval to treat humans, inhibited the replication of SARS-CoV-2, the virus that causes COVID-19, in human cell cultures and in a mouse model, leading to much lower viral loads. X-ray crystallography gave us a strong indication of how this drug works, and we became confident that it has a chance to work in humans. Nir Drayman, University of Chicago

Masitinib Inhibits the Replication of SARS-CoV-2 in Preclinical Models

Masitinib Inhibits the Replication of SARS-CoV-2 in Preclinical Models
technologynetworks.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from technologynetworks.com Daily Mail and Mail on Sunday newspapers.

Remédio usado em cães é aposta de pesquisadores para tratar covid-19

Remédio usado em cães é aposta de pesquisadores para tratar covid-19
correiobraziliense.com.br - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from correiobraziliense.com.br Daily Mail and Mail on Sunday newspapers.

Remédio usado em cachorros é a aposta de pesquisadores para tratar COVID-19

Remédio usado em cachorros é a aposta de pesquisadores para tratar COVID-19
em.com.br - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from em.com.br Daily Mail and Mail on Sunday newspapers.

Existing drug may be effective in treating COVID-19

Existing drug may be effective in treating COVID-19 A new University of Chicago study has found that the drug masitinib may be effective in treating COVID-19. The drug, which has undergone several clinical trials for human conditions but has not yet received approval to treat humans, inhibited the replication of SARS-CoV-2 in human cell cultures and in a mouse model, leading to much lower viral loads. Researchers at UChicago s Pritzker School of Molecular Engineering (PME), working with collaborators at Argonne National Laboratory and around the world, also found that the drug could be effective against many types of coronaviruses and picornaviruses. Because of the way it inhibits replication, it has also been shown to remain effective in the face of COVID-19 variants.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.